Dexcom

NASDAQ: DXCM

$61.26USD

-0.31 (-0.50%)At close: Apr 27, 14:05 UTC

Open

$61.28

Prev. Close

$61.29

High

$61.28

Low

$61.26

Key Stats

Market Cap

$24.01B

Dividend Yield

–

P/E Ratio

28.7

EPS

1.46

Revenue

$4.03B

Avg. Volume

3.4M

TL;DR

Dexcom outperforms OPKO Health in revenue and analyst ratings, indicating stronger investment potential within the competitive medical technology sector.

Recently from Cashu

DexCom Sees Insurance Expansion Benefits Amid Concerns Over Stock Performance and Investor Confidence

DexCom leverages a significant shift in the insurance reimbursement landscape, looking to capitalize on expanded coverage for its continuous glucose monitoring (CGM) systems. This recent development a…

Cashu Markets·7h ago

Dexcom Advances FDA Approval Journey with Innovative Device Studies for Diabetes Management

Dexcom Charts Path Toward FDA Approval with Innovative Device Studies Dexcom takes significant strides in the medical device landscape by announcing its plan to submit an Investigational Device Exempt…

Cashu Markets·28 days ago

Dexcom Innovates Continuous Glucose Monitoring Amidst Competitive Diabetes Management Landscape

Dexcom Advances Continuous Glucose Monitoring Technology Amid Competitive Landscape Dexcom, a leader in continuous glucose monitoring (CGM) technology, continues to strengthen its position in the diab…

Cashu Markets·1 month ago

Dexcom Faces Mixed Analyst Views Amid Growing Competition in CGM Market

Dexcom Navigates Diverse Analyst Sentiment Amidst Competitive Landscape In recent months, Dexcom, Inc. (NASDAQ:DXCM) finds itself under the scrutiny of market analysts who provide a spectrum of foreca…

Cashu Markets·2 months ago